As the trading floor lights flickered to life in early 2026, a new psychological benchmark took hold of the financial world: 8,000. Just two years after the S&P 500 first crossed the 5,000 threshold, a growing chorus of Wall Street’s most influential strategists is projecting that
As the 44th Annual J.P. Morgan Healthcare Conference kicked off this week in San Francisco, all eyes turned to UnitedHealth Group (NYSE:UNH), the diversified healthcare giant that serves as the primary barometer for the multi-trillion-dollar U.S. medical sector. On January 12, 2026, the company issued a critical
A cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
The first trading week of 2026 has delivered a complex narrative for the technology sector, defined by a stark contrast between groundbreaking innovation and a massive institutional shift in capital. As the world gathered for the Consumer Electronics Show (CES) in Las Vegas, Nvidia Corp. (NASDAQ: NVDA) once again seized
As the first week of 2026 comes to a close, the financial markets are undergoing a significant structural shift. The broad-based "rising tide" that lifted almost all sectors throughout 2025 has begun to fragment, giving way to a more discerning "Internal Repair" phase. Investors are increasingly rotating capital out of
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in Q3, starting with LeMaitre (NASDAQ:LMAT).
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
December 16, 2025 – The "buying the dip" investment strategy, which involves purchasing an asset after its price has declined with the anticipation of a subsequent recovery, has seen significant relevance and success in financial markets throughout 2025. This approach leverages temporary market downturns as opportunities to acquire assets at a
Despite recent pockets of volatility and "slips" in the U.S. stock market during late 2025, a robust corporate profit outlook is emerging as a powerful counter-narrative, fueling investor optimism and suggesting that still-higher prices for American equities may be on the horizon. While the Cboe Volatility Index (VIX) saw
